| abstract |
(57) [Summary]nUsed for the treatment and / or prevention of diseases or conditions where the prevention and inhibition of CD154 modulation and / or CD154: CD40 interaction has therapeutically advantageous, wherein the heavy and light chain CDRs have the amino acid sequences as defined There are provided CD154 binding molecules, in particular antibodies against human CD154, in particular human antibodies against human CD154. |